Difficulty: Medium
Average Score: 70%
Practice
Which of the following is a reversible inhibitor of platelet cyclooxygenase?
Correct answer
C
Rationale
In the context of pharmacology, specifically focusing on CNS drugs classification, understanding the mechanism of action of different medications is crucial. In this question, the correct answer is option C) Ibuprofen, which is a reversible inhibitor of platelet cyclooxygenase.
Ibuprofen belongs to the class of nonsteroidal anti-inflammatory drugs (NSAIDs) and exerts its effects by inhibiting cyclooxygenase enzymes, particularly COX-1 and COX-2. By inhibiting these enzymes, ibuprofen reduces the production of prostaglandins, which are involved in the inflammatory response and platelet aggregation. As a reversible inhibitor of platelet cyclooxygenase, ibuprofen can reduce platelet aggregation and potentially decrease the risk of clot formation.
Analyzing the other options:
- A) Alprostadil is a prostaglandin E1 analog used to treat erectile dysfunction and certain heart conditions. It does not inhibit platelet cyclooxygenase.
- B) Aspirin is an irreversible inhibitor of platelet cyclooxygenase, specifically targeting COX-1. It irreversibly acetylates the enzyme, leading to prolonged inhibition of platelet function.
- D) LTC4 is a leukotriene involved in the inflammatory response, but it is not a reversible inhibitor of platelet cyclooxygenase.
Educationally, this question highlights the importance of understanding the specific mechanisms of action of different drugs, especially in the context of pharmacology. It emphasizes the distinctions between reversible and irreversible inhibitors of platelet cyclooxygenase and how these mechanisms can impact clinical outcomes in terms of platelet function and clotting processes. Understanding these concepts is essential for healthcare professionals in making informed decisions regarding drug therapy and patient care.
Ibuprofen belongs to the class of nonsteroidal anti-inflammatory drugs (NSAIDs) and exerts its effects by inhibiting cyclooxygenase enzymes, particularly COX-1 and COX-2. By inhibiting these enzymes, ibuprofen reduces the production of prostaglandins, which are involved in the inflammatory response and platelet aggregation. As a reversible inhibitor of platelet cyclooxygenase, ibuprofen can reduce platelet aggregation and potentially decrease the risk of clot formation.
Analyzing the other options:
- A) Alprostadil is a prostaglandin E1 analog used to treat erectile dysfunction and certain heart conditions. It does not inhibit platelet cyclooxygenase.
- B) Aspirin is an irreversible inhibitor of platelet cyclooxygenase, specifically targeting COX-1. It irreversibly acetylates the enzyme, leading to prolonged inhibition of platelet function.
- D) LTC4 is a leukotriene involved in the inflammatory response, but it is not a reversible inhibitor of platelet cyclooxygenase.
Educationally, this question highlights the importance of understanding the specific mechanisms of action of different drugs, especially in the context of pharmacology. It emphasizes the distinctions between reversible and irreversible inhibitors of platelet cyclooxygenase and how these mechanisms can impact clinical outcomes in terms of platelet function and clotting processes. Understanding these concepts is essential for healthcare professionals in making informed decisions regarding drug therapy and patient care.